Edition:
United States

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

96.40EUR
11:35am EDT
Change (% chg)

€0.37 (+0.39%)
Prev Close
€96.03
Open
€96.54
Day's High
€96.75
Day's Low
€96.05
Volume
334,778
Avg. Vol
469,478
52-wk High
€115.20
52-wk Low
€90.00

Chart for

About

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company operates through four business segments: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnol... (more)

Overall

Beta: 1.03
Market Cap(Mil.): €12,411.13
Shares Outstanding(Mil.): 129.24
Dividend: 1.20
Yield (%): 1.25

Financials

  Industry Sector
P/E (TTM): -- 31.87 16.33
EPS (TTM): -- -- --
ROI: -- 15.11 14.66
ROE: -- 16.37 13.99

Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod

FRANKFURT European regulators on Thursday granted market approval for Merck KGaA and Pfizer's immuno-oncology drug Bavencio to treat a rare and aggressive type of skin cancer called Merkel cell carcinoma.

3:21am EDT

Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod

FRANKFURT, Sept 21 European regulators on Thursday granted market approval for Merck KGaA and Pfizer's immuno-oncology drug Bavencio to treat a rare and aggressive type of skin cancer called Merkel cell carcinoma.

3:19am EDT

BRIEF-Merck KGaA's Bavencio drug wins EU approval for Merkel cell carcinoma

* European commission approves Bavencio (avelumab) for metastatic Merkel cell carcinoma For the full story: Further company coverage:

3:17am EDT

RPT-UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health

FRANKFURT/LONDON, Sept 8 Germany's Merck KGaA has hired JP Morgan to sell its consumer health business, which includes brands such as Seven Seas vitamins and could be worth around $4.5 billion.

Sep 11 2017

Germany's Merck hires JP Morgan to sell consumer health

FRANKFURT/LONDON Germany's Merck KGaA has hired JP Morgan to sell its consumer health business, which includes brands such as Seven Seas vitamins and could be worth around $4.5 billion.

Sep 08 2017

Germany's Merck hires JP Morgan to sell consumer health

FRANKFURT/LONDON Germany's Merck KGaA has hired JP Morgan to sell its consumer health business, which includes brands such as Seven Seas vitamins and could be worth around $4.5 billion.

Sep 08 2017

UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health

* Pfizer not interested in more consumer health -source (Adds previous talks with Nestle, deal value)

Sep 08 2017

Germany's Merck hires JP Morgan to advise on consumer health review

FRANKFURT, Sept 8 Merck KGaA has hired investment bank JP Morgan as a financial adviser to evaluate strategic options for its consumer health business, a spokesman for the German company said on Friday.

Sep 08 2017

Germany's Merck considers sale of consumer health business

FRANKFURT/COLOGNE Germany's Merck KGaA is considering selling its consumer healthcare business which has sales of $1 billion a year to help fund more research into prescription drugs and amid declines in the company's separate liquid crystal business.

Sep 05 2017

UPDATE 3-Germany's Merck considers sale of consumer health business

* Shares rise more than 2 percent (Adds background on consumer health industry)

Sep 05 2017

Earnings vs. Estimates